Adamas Pharmaceuticals, Inc. ADMS

Adamas Pharmaceuticals, Inc. DIO Ratio 2011-2025 | ADMS

Annual DIO Ratio Adamas Pharmaceuticals, Inc.

2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
1.31 K	779	2.95 K	36.6 K	-	-	-	-	-	-

All numbers in USD currency

Maximum	Minimum	Average
36.6 K	779	10.4 K

Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
Aclaris Therapeutics ACRS	42.1	$ 3.0	-0.99 %	$ 232 M	USA
Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
Aptorum Group Limited APM	12	$ 1.1	-3.51 %	$ 6 M	China
BioDelivery Sciences International BDSI	321	-	-4.8 %	$ 255 M	USA
Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
Acasti Pharma ACST	136	-	4.01 %	$ 150 M	Canada
Berkeley Lights BLI	246	-	-7.31 %	$ 87 M	USA
Albireo Pharma ALBO	26.1	-	-0.23 %	$ 916 M	USA
Catalyst Biosciences CBIO	410	$ 12.12	-1.86 %	$ 798 M	USA
Amphastar Pharmaceuticals AMPH	132	$ 26.86	-0.96 %	$ 1.3 B	USA
BeiGene, Ltd. BGNE	304	-	0.49 %	$ 251 B	Cayman-islands
Anika Therapeutics ANIK	247	$ 9.53	-0.21 %	$ 140 M	USA
bluebird bio BLUE	125	-	-	$ 546 M	USA
Cellectis S.A. CLLS	23.3	$ 4.95	4.2 %	$ 116 M	France
Arena Pharmaceuticals ARNA	160	-	-6.81 %	$ 3.04 B	USA
Axon Enterprise AXON	116	$ 583.1	-0.13 %	$ 44.2 B	USA
Aytu BioScience AYTU	209	$ 2.55	4.08 %	$ 16 M	USA
AstraZeneca PLC AZN	206	$ 92.68	-0.24 %	$ 96.9 B	Britain
ChromaDex Corporation CDXC	114	-	-0.88 %	$ 598 M	USA
Acorda Therapeutics ACOR	345	-	-24.86 %	$ 820 K	USA
Biohaven Pharmaceutical Holding Company Ltd. BHVN	239	$ 11.43	2.65 %	$ 739 M	USA